Enliven Therapeutics
ELVN
ELVN
63 hedge funds and large institutions have $798M invested in Enliven Therapeutics in 2023 Q2 according to their latest regulatory filings, with 25 funds opening new positions, 19 increasing their positions, 10 reducing their positions, and 7 closing their positions.
Holders
63
Holders Change
+18
Holders Change %
+40%
% of All Funds
0.99%
Holding in Top 10
6
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-14.29%
% of All Funds
0.09%
New
25
Increased
19
Reduced
10
Closed
7
Calls
$48K
Puts
–
Net Calls
+$48K
Net Calls Change
-$8.15M
Top Buyers
1 |
1
BlackRock
New York
|
$31.6M |
2 |
2
Vanguard Group
Malvern,
Pennsylvania
|
$23.3M |
3 |
![]()
3
Fidelity Investments
Boston,
Massachusetts
|
$81.7M |
4 |
CC
4
Commodore Capital
New York
|
$47.9M |
5 |
5
State Street
Boston,
Massachusetts
|
$9.52M |